<DOC>
	<DOCNO>NCT00908362</DOCNO>
	<brief_summary>Airway dendritic cell ( DCs ) play key role smoke-related lung disease . In study , researcher investigate effect fluticasone salmeterol human airway DCs smoker . The researcher hypothesize fluticasone salmeterol impact number characteristic airway DCs smoker .</brief_summary>
	<brief_title>Impact Fluticasone Salmeterol Airway Dendritic Cells ( DCs ) Smokers</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>Men age 30 60 year At least 15 year smoke Current smoker , least 10 cigarette per day Any acute chronic disease ( except COPD oder hypertension ) Any regular medication ( except drug hypertension ) FEV1 &lt; 80 % predict Oxygen saturation &lt; 90 % Acute infection low respiratory tract last 7 day first day study</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Dendritic cell</keyword>
	<keyword>Airway</keyword>
	<keyword>Smoker</keyword>
	<keyword>COPD</keyword>
</DOC>